StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$305.06−5.21 (-1.68%)

Close on Nov 17, 2026Market cap $8.52BP/E –Yield –

Praxis Precision Medicines operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Praxis Precision Medicines's operating cash flow for the twelve months ending Jun 30, 2026 was -$305.08M. For fiscal 2025 it was -$249.07M. The highest annual figure on record is -$33.42M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$249.07M–
FY2024Dec 31, 2024-$131.76M–
FY2023Dec 31, 2023-$111.14M–
FY2022Dec 31, 2022-$185.04M–
FY2021Dec 31, 2021-$124.55M–
FY2020Dec 31, 2020-$52.62M–
FY2019Dec 31, 2019-$33.42M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$77.54M–
Q1 FY2026Mar 31, 2026-$86.15M–
Q4 FY2025Dec 31, 2025-$76.33M–
Q3 FY2025Sep 30, 2025-$65.06M–
Q2 FY2025Jun 30, 2025-$54.68M–
Q1 FY2025Mar 31, 2025-$53.01M–
Q4 FY2024Dec 31, 2024-$56.12M–
Q3 FY2024Sep 30, 2024-$27.50M–
Q2 FY2024Jun 30, 2024-$27.28M–
Q1 FY2024Mar 31, 2024-$20.86M–
Q4 FY2023Dec 31, 2023-$23.86M–
Q3 FY2023Sep 30, 2023-$23.22M–
Q2 FY2023Jun 30, 2023-$31.21M–
Q1 FY2023Mar 31, 2023-$32.85M–
Q4 FY2022Dec 31, 2022-$28.81M–
Q3 FY2022Sep 30, 2022-$44.92M–
Q2 FY2022Jun 30, 2022-$57.21M–
Q1 FY2022Mar 31, 2022-$54.11M–
Q4 FY2021Dec 31, 2021-$44.86M–
Q3 FY2021Sep 30, 2021-$23.96M–
Q2 FY2021Jun 30, 2021-$30.01M–
Q1 FY2021Mar 31, 2021-$25.72M–
Q4 FY2020Dec 31, 2020-$20.23M–
Q3 FY2020Sep 30, 2020-$13.88M–
Q2 FY2020Jun 30, 2020-$9.94M–
Q1 FY2020Mar 31, 2020-$8.57M–
Q4 FY2019Dec 31, 2019-$9.95M–

More Praxis Precision Medicines figures

See a number that looks wrong?